Precigen (PGEN) Non-Current Assets (2012 - 2026)

Precigen (PGEN) reported Non-Current Assets of $37.0 million for Q1 2026, down 16.36% year-over-year from $44.2 million in Q1 2025, and down 8.23% quarter-over-quarter from $40.3 million in Q4 2025.

Precigen (PGEN) Non-Current Assets (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Non-Current Assets data on file, last reported at $37.0 million in Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $37.0 million, down 16.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $158.0 million (down 14.78% YoY), and the FY2025 annual result was $40.3 million, down 6.03% from the prior year.
  • Non-Current Assets declined to $37.0 million in Q1 2026 per PGEN's latest filing, from $40.3 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $180.6 million in Q1 2022 and troughed at $37.0 million in Q1 2026.
  • A 5-year average of $79.2 million and a median of $82.3 million in 2023 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Assets plunged 56.91% in 2022, then rose 1.31% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $97.8 million in 2022, then retreated by 15.88% to $82.3 million in 2023, then slumped by 47.92% to $42.9 million in 2024, then retreated by 6.03% to $40.3 million in 2025, then dropped by 8.23% to $37.0 million in 2026.
  • Business Quant data shows PGEN's Non-Current Assets at $37.0 million in Q1 2026, $40.3 million in Q4 2025, and $41.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 62,953.78
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 289.41 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4.56 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 30.30 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.37 Bn 94.37 Bn - 39.71 Mn
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn 36.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 36.96 Mn
Dec 31, 2025 40.27 Mn
Sep 30, 2025 41.67 Mn
Jun 30, 2025 39.14 Mn
Mar 31, 2025 44.19 Mn
Dec 31, 2024 42.85 Mn
Sep 30, 2024 48.96 Mn
Jun 30, 2024 49.45 Mn
Mar 31, 2024 85.30 Mn
Dec 31, 2023 82.29 Mn
Sep 30, 2023 97.70 Mn
Jun 30, 2023 101.90 Mn
Mar 31, 2023 103.80 Mn
Dec 31, 2022 97.82 Mn
Sep 30, 2022 96.44 Mn
Jun 30, 2022 156.61 Mn
Mar 31, 2022 180.63 Mn
Dec 31, 2021 203.23 Mn
Sep 30, 2021 223.81 Mn
Jun 30, 2021 245.89 Mn